SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?


To: JF2155 who wrote (517)3/26/1999 12:35:00 AM
From: rick barrows  Read Replies (2) | Respond to of 2515
 
I read that they were going to present several abstracts at the AACR on another board. To confirm I went to www.aacr.org and while I did not search all of the info I was able to confirm that abstracts numbered 154 and 155 are studies where C-225 is used in combination with other agents to treat human cancer xenografts in mice. The overview seemed to indicate that the addition of C-225 was of significant value.